Jazz Pharmaceuticals Plc (JAZZ)
186.67
-3.79
(-1.99%)
USD |
NASDAQ |
Mar 03, 16:00
187.02
+0.35
(+0.19%)
After-Hours: 20:00
Jazz Pharmaceuticals Research and Development Expense (Annual) : 782.74M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Alkermes Plc | 318.36M |
| Amarin Corp. Plc | 19.85M |
| Medtronic Plc | 2.732B |
| Perrigo Co. Plc | 95.40M |
| STERIS Plc (Ireland) | 107.65M |